What is Osimertinib: Uses, Dosage, Side Effects and More

Osimertinib is a targeted cancer medication that specifically treats certain types of lung cancer. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking specific proteins that help cancer cells grow and spread.

This medication has revolutionized treatment for patients with non-small cell lung cancer (NSCLC) that has specific genetic mutations. It's designed to be more precise than traditional chemotherapy, targeting only the cancer cells while generally causing fewer severe side effects.

What is Osimertinib?

Osimertinib is an oral cancer medication that targets specific genetic mutations in lung cancer cells. It's what doctors call a "third-generation" tyrosine kinase inhibitor, which means it's been designed to overcome resistance that can develop with older similar medications.

The drug works by blocking a protein called EGFR (epidermal growth factor receptor) that has become mutated in certain lung cancers. When this protein is blocked, the cancer cells can't receive the signals they need to grow and multiply, which helps slow or stop the cancer's progression.

Osimertinib is taken as a tablet once daily, making it more convenient than many other cancer treatments that require hospital visits for infusions. This allows many patients to continue their treatment at home while maintaining more of their normal daily routines.

What is Osimertinib Used For?

Osimertinib is primarily used to treat non-small cell lung cancer (NSCLC) that has specific EGFR mutations. Your doctor will test your cancer tissue to confirm these mutations are present before prescribing this medication.

The medication is approved for two main situations. First, it's used as a first-line treatment for newly diagnosed advanced NSCLC with certain EGFR mutations. This means it can be the first cancer treatment you receive after diagnosis, rather than starting with chemotherapy.

Second, osimertinib treats NSCLC that has developed resistance to other EGFR inhibitors and has a specific mutation called T790M. This mutation can develop over time as cancer cells adapt to previous treatments, and osimertinib was specifically designed to overcome this resistance.

The drug is also used when lung cancer has spread to the brain, as it can cross the blood-brain barrier more effectively than some other targeted therapies. This makes it particularly valuable for patients whose cancer has metastasized to the brain.

How Does Osimertinib Work?

Osimertinib works by blocking mutated EGFR proteins that act like faulty switches in cancer cells. In healthy cells, EGFR proteins help control normal cell growth, but in cancer cells, these proteins become overactive and drive uncontrolled growth.

Think of it like disconnecting a broken accelerator pedal in a car that's stuck in the "go" position. By blocking these overactive proteins, osimertinib helps slow down or stop the cancer cells from multiplying and spreading to other parts of your body.

This medication is considered a strong and effective targeted therapy. Unlike chemotherapy, which affects both healthy and cancerous cells, osimertinib specifically targets the molecular changes that make cancer cells different from normal cells.

The drug also has the ability to cross the blood-brain barrier, which is a protective layer that normally keeps many substances from entering the brain. This makes osimertinib particularly effective against lung cancer that has spread to the brain.

How Should I Take Osimertinib?

Osimertinib is taken once daily as a tablet, and you should take it at the same time each day to maintain consistent levels in your body. You can take it with or without food, but try to be consistent with your choice to help maintain steady absorption.

Swallow the tablet whole with a glass of water. Don't crush, chew, or break the tablet, as this can affect how the medication is absorbed and potentially cause side effects. If you have trouble swallowing tablets, talk to your healthcare team about alternative ways to take your medication.

If you need to take the medication through a feeding tube, your healthcare provider can show you how to dissolve the tablet in water safely. This should only be done following specific instructions from your medical team.

It's important to take osimertinib exactly as prescribed, even if you're feeling better. Cancer medications work best when taken consistently, and skipping doses can allow cancer cells to start growing again.

How Long Should I Take Osimertinib For?

You'll typically continue taking osimertinib for as long as it's working to control your cancer and you're tolerating it well. This could be months or even years, depending on how your cancer responds to the treatment.

Your doctor will monitor your progress through regular scans and blood tests to see how well the medication is working. These check-ups help determine whether you should continue with the same treatment or if adjustments are needed.

Some patients take osimertinib for several years if it continues to be effective. Others may need to switch to different treatments if their cancer develops resistance to the medication or if side effects become too challenging to manage.

Never stop taking osimertinib suddenly without talking to your doctor first. Even if you're experiencing side effects, your healthcare team can often adjust your treatment plan to help you continue benefiting from the medication safely.

What Are the Side Effects of Osimertinib?

While osimertinib generally causes fewer severe side effects than traditional chemotherapy, it can still cause some uncomfortable symptoms. Most side effects are manageable with proper care and monitoring from your healthcare team.

The most common side effects you might experience include diarrhea, skin rash, dry skin, nail changes, and fatigue. These symptoms often improve over time as your body adjusts to the medication, and your healthcare team can provide strategies to help manage them.

Here are the more common side effects that patients typically experience:

• Diarrhea, which can usually be managed with dietary changes and over-the-counter medications
• Skin rash and dry skin, often appearing within the first few weeks of treatment
• Changes to your nails, including brittleness or changes in color
• Fatigue and feeling more tired than usual
• Decreased appetite and potential weight loss
• Mouth sores or stomatitis

These common side effects, while bothersome, are usually mild to moderate and can be managed with supportive care. Your healthcare team will work with you to minimize these effects and help you maintain your quality of life.

There are also some less common but more serious side effects that require immediate medical attention. While these occur in fewer patients, it's important to be aware of them so you can seek help quickly if needed.

More serious side effects that require prompt medical attention include:

• Lung problems, including inflammation of the lungs (pneumonitis), which can cause shortness of breath or cough
• Heart problems, including changes in heart rhythm or decreased heart function
• Severe skin reactions that cover large areas of your body
• Eye problems, including vision changes or severe eye pain
• Blood clotting problems, which can cause swelling or pain in your legs

If you experience any of these serious symptoms, contact your healthcare provider immediately. Early detection and treatment of these side effects can help prevent more serious complications.

Who Should Not Take Osimertinib?

Osimertinib isn't suitable for everyone, and your doctor will carefully evaluate whether it's the right treatment for your specific situation. The medication is only effective for cancers with specific EGFR mutations, so genetic testing is essential before starting treatment.

You shouldn't take osimertinib if you're allergic to the medication or any of its ingredients. Tell your doctor about any previous allergic reactions to medications, especially other cancer treatments or tyrosine kinase inhibitors.

Pregnant women should not take osimertinib as it can harm the developing baby. If you're a woman of childbearing age, you'll need to use effective birth control during treatment and for at least six weeks after your last dose.

Men taking osimertinib should also use effective birth control during treatment and for at least four months after the last dose, as the medication can affect sperm and potentially harm a developing baby.

People with certain heart conditions, severe kidney problems, or severe liver disease may need special monitoring or dose adjustments. Your doctor will review your complete medical history to determine if osimertinib is safe for you.

Osimertinib Brand Names

Osimertinib is most commonly known by its brand name Tagrisso, which is manufactured by AstraZeneca. This is the name you'll typically see on your prescription bottle and medication packaging.

In some countries, osimertinib might be available under different brand names or as a generic medication. However, Tagrisso remains the most widely recognized and available form of this medication globally.

Always make sure you're receiving the correct medication by checking both the generic name (osimertinib) and brand name (Tagrisso) with your pharmacist. This helps ensure you're getting the right treatment and proper dosage.

Osimertinib Alternatives

If osimertinib isn't suitable for you or stops working effectively, several alternative treatments are available for EGFR-mutated lung cancer. Your doctor will consider your specific cancer characteristics and treatment history when recommending alternatives.

Other EGFR inhibitors include erlotinib (Tarceva) and afatinib (Gilotrif), which are often used as first-line treatments. These medications work similarly to osimertinib but may be better suited for certain types of EGFR mutations or patient situations.

For patients whose cancer has progressed on multiple targeted therapies, combination treatments might be recommended. These could include osimertinib combined with chemotherapy or other targeted drugs, depending on your cancer's specific characteristics.

Traditional chemotherapy remains an important option, especially for patients whose cancers don't have targetable mutations or have developed resistance to multiple targeted therapies. Your oncologist will help determine the best treatment sequence for your individual situation.

Is Osimertinib Better Than Erlotinib?

Osimertinib and erlotinib are both effective EGFR inhibitors, but they work best in different situations. Osimertinib is generally considered more effective for first-line treatment of EGFR-mutated lung cancer and has shown superior results in clinical trials.

Studies have shown that osimertinib typically provides longer progression-free survival compared to erlotinib when used as initial treatment. This means patients often go longer before their cancer starts growing again when treated with osimertinib first.

Osimertinib also has better penetration into the brain, making it more effective for preventing or treating brain metastases. This is particularly important since lung cancer commonly spreads to the brain.

However, erlotinib might still be preferred in certain situations, such as when cost is a major factor or when a patient has specific side effects that make osimertinib unsuitable. Your doctor will consider all these factors when recommending the best treatment for your specific situation.